ethidium has been researched along with carboplatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holler, E; Malathi, R; Natarajan, G | 1 |
| Avadhani, N; Guha, M; Jackson, M; Mason, N; Serada, N; Sheehan, M; Srinivasan, S | 1 |
2 other study(ies) available for ethidium and carboplatin
| Article | Year |
|---|---|
Increased DNA-binding activity of cis-1,1-cyclobutanedicarboxylatodiammineplatinum(II) (carboplatin) in the presence of nucleophiles and human breast cancer MCF-7 cell cytoplasmic extracts: activation theory revisited.
Topics: Antineoplastic Agents; Breast Neoplasms; Carboplatin; Cell Extracts; DNA; Ethidium; Fluorescence; Humans; Methionine; Tumor Cells, Cultured | 1999 |
Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype.
Topics: Animals; Biomarkers, Tumor; Biopsy; Bone Neoplasms; Cancer Vaccines; Carboplatin; Cell Line, Tumor; DNA, Mitochondrial; Dog Diseases; Dogs; Ethidium; Genome, Mitochondrial; Mitochondria; Neoplasm Invasiveness; Osteosarcoma; Prognosis; Treatment Outcome | 2018 |